PRNP and Parkinson disease: However, PrPC-deficient mice do not exhibit altered amyloid-β toxicity [102–105] and there was no protective effect of PrPC in mouse models of other neurodegenerative diseases, including Parkinson's and Huntington's disease, as well as a mouse model of tauopathy [124, 132].